Neue Indikation PIK3CA-mutiertes Mammakarzinom: Erste Erfahrungen aus dem molekularpathologischen Routinelabor

Strohkamp S, Schmidt S, Falk M, Tiemann K. Neue Indikation PIK3CA-mutiertes Mammakarzinom: Erste Erfahrungen aus dem molekularpathologischen Routinelabor. Journal Oncologie 2021

Influence of Biopsy Technique on Molecular Genetic Tumor Characterization in Non-Small Cell Lung Cancer-The Prospective, Randomized, Single-Blinded, Multicenter PROFILER Study Protocol

Haentschel M, et al. Influence of Biopsy Technique on Molecular Genetic Tumor Characterization in Non-Small Cell Lung Cancer-The Prospective, Randomized, Single-Blinded, Multicenter PROFILER Study Protocol. Diagnostics (Basel) 2020 Jul 6;10(7):459. doi: 10.3390/diagnostics10070459

Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer

Latteyer S, et al. Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer. Endocrine 2016 Dec;54(3):733-741. doi:10.1007/s12020-016-1080-9

Risk stratification of EGFR + lung cancer diagnosed with panel-based next-generation sequencing

Christopoulos P, et al. Risk stratification of EGFR + lung cancer diagnosed with panel-based next-generation sequencing. Lung Cancer 2020 Oct;148:105-112. doi: 10.1016/j.lungcan.2020.08.007